These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38423871)
1. Ethanolamine as a biomarker and biomarker-based therapy for diabetic retinopathy in glucose-well-controlled diabetic patients. Hu G; Gu L; Wang R; Jian Q; Lv K; Xia M; Lai M; Shen T; Hu J; Yang S; Ye C; Zhang X; Wang Y; Xu X; Zhang F Sci Bull (Beijing); 2024 Jun; 69(12):1920-1935. PubMed ID: 38423871 [TBL] [Abstract][Full Text] [Related]
2. Inter-Relations between Dietary Patterns and Glycemic Control-Related Biomarkers on Risk of Retinopathy in Type 2 Diabetes. Wu YJ; Hsu CC; Hwang SJ; Lin KD; Lin PC; Huang YF; Lee CH; Chang CI; Huang MC Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064717 [TBL] [Abstract][Full Text] [Related]
3. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes. Elbana KA; Salem HM; Abdel Fattah NR; Etman E Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644 [TBL] [Abstract][Full Text] [Related]
4. Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes. Lu J; Ma X; Zhang L; Mo Y; Ying L; Lu W; Zhu W; Bao Y; Zhou J J Diabetes Investig; 2019 May; 10(3):753-759. PubMed ID: 30306722 [TBL] [Abstract][Full Text] [Related]
5. A five-year prospective study of diabetic retinopathy progression in chinese type 2 diabetes patients with "well-controlled" blood glucose. Jin P; Peng J; Zou H; Wang W; Fu J; Shen B; Bai X; Xu X; Zhang X PLoS One; 2015; 10(4):e0123449. PubMed ID: 25849536 [TBL] [Abstract][Full Text] [Related]
6. The effects of Bushen Yiqi Huoxue prescription and its disassembled prescriptions on a diabetic retinopathy model in Sprague Dawley rats. Xie M; Deng L; Yu Y; Xie X; Zhang M Biomed Pharmacother; 2021 Jan; 133():110920. PubMed ID: 33232926 [TBL] [Abstract][Full Text] [Related]
7. Diabetic retinopathy risk factors: plasma erythropoietin as a risk factor for proliferative diabetic retinopathy. Gholamhossein Y; Behrouz H; Asghar Z Korean J Ophthalmol; 2014 Oct; 28(5):373-8. PubMed ID: 25276078 [TBL] [Abstract][Full Text] [Related]
8. Early risk stratification in pediatric type 1 diabetes. Broe R Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648 [TBL] [Abstract][Full Text] [Related]
9. EFFECTS OF GLYCEMIC VARIABILITY ON THE PROGRESSION OF DIABETIC RETINOPATHY AMONG PATIENTS WITH TYPE 2 DIABETES. Park JY; Hwang JH; Kang MJ; Sim HE; Kim JS; Ko KS Retina; 2021 Jul; 41(7):1487-1495. PubMed ID: 33252581 [TBL] [Abstract][Full Text] [Related]
10. The Risk Factors for Diabetic Retinopathy in a Chinese Population: A Cross-Sectional Study. Sun Q; Jing Y; Zhang B; Gu T; Meng R; Sun J; Zhu D; Wang Y J Diabetes Res; 2021; 2021():5340453. PubMed ID: 33575359 [TBL] [Abstract][Full Text] [Related]
11. Effect of basal insulin supplement therapy on diabetic retinopathy in short-duration type 2 diabetes: A one-year randomized parallel-group trial. Mu PW; Tang XX; Tan Y; Wang YN; Lin S; Wang MM; Shu J; Wang J; Zhang YJ; Liang H; Lin BR; Cai MY; Chen YM J Diabetes; 2019 Dec; 11(12):949-957. PubMed ID: 30973204 [TBL] [Abstract][Full Text] [Related]
12. Serum glycated albumin predicts the progression of diabetic retinopathy--a five year retrospective longitudinal study. Pan J; Li Q; Zhang L; Jia L; Tang J; Bao Y; Jia W J Diabetes Complications; 2014; 28(6):772-8. PubMed ID: 25073934 [TBL] [Abstract][Full Text] [Related]
13. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy. Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349 [TBL] [Abstract][Full Text] [Related]
14. Incidence and Risk Factors for Developing Diabetic Retinopathy among Youths with Type 1 or Type 2 Diabetes throughout the United States. Wang SY; Andrews CA; Herman WH; Gardner TW; Stein JD Ophthalmology; 2017 Apr; 124(4):424-430. PubMed ID: 27914837 [TBL] [Abstract][Full Text] [Related]
15. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy. Zehetner C; Kirchmair R; Kralinger M; Kieselbach G Acta Ophthalmol; 2013 Sep; 91(6):e470-3. PubMed ID: 23452413 [TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy. Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33). Raman R; Gupta A; Kulothungan V; Sharma T Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770 [TBL] [Abstract][Full Text] [Related]
18. Retinal Vessel Geometry and the Incidence and Progression of Diabetic Retinopathy. Lim LS; Chee ML; Cheung CY; Wong TY Invest Ophthalmol Vis Sci; 2017 May; 58(6):BIO200-BIO205. PubMed ID: 28750414 [TBL] [Abstract][Full Text] [Related]
19. Retinopathy among Chinese subjects with type 2 diabetes mellitus in Shanghai: A community-based follow-up study. Qin F; Jing L; Jia L; Lou J; Feng Y; Long W; Yang H; Shi R Int J Health Plann Manage; 2019 Jul; 34(3):998-1012. PubMed ID: 31373063 [TBL] [Abstract][Full Text] [Related]
20. The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy. Klein BE; Knudtson MD; Tsai MY; Klein R Arch Ophthalmol; 2009 Sep; 127(9):1175-82. PubMed ID: 19752427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]